Steven Wyatt Queener

Title: Innovations of Steven Wyatt Queener

Introduction

Steven Wyatt Queener is an accomplished inventor based in Indianapolis, IN (US). He has made significant contributions to the field of biomedical research, particularly in the study of Alzheimer's disease and other neurological disorders. With a total of 2 patents, his work has the potential to impact the development of new therapeutic strategies.

Latest Patents

One of Steven's latest patents focuses on a novel β-secretase and the modulation of β-secretase activity. This invention involves a method of partially purifying this novel β-secretase and its application in assays designed to screen for potential drug candidates against Alzheimer's disease and other neurological conditions. The novel β-secretase has an estimated molecular weight of about 32-39 kDa or 22-26 kDa in HEK293 cell membrane extracts and human brain samples, respectively. This was calculated from radiation inactivation analysis, and it has a pH optimum at approximately pH 6.5-7.0.

Career Highlights

Throughout his career, Steven has worked with notable companies such as Scios Inc. and Eli Lilly and Company. His experience in these organizations has contributed to his expertise in the field of drug development and neurological research.

Collaborations

Steven has collaborated with esteemed colleagues, including Ziyang Zhong and Barbara Cordell. These partnerships have further enriched his research and innovation efforts.

Conclusion

Steven Wyatt Queener's contributions to the field of biomedical research, particularly through his patents related to β-secretase, highlight his role as a significant inventor. His work continues to pave the way for advancements in the treatment of neurological diseases.